Toolkit/CRISPR-based assays

CRISPR-based assays

Assay Method·Research·Since 2026

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

These reporters support real-time tracking of infection dynamics and host-virus interactions and power diagnostic platforms including reporter viruses, CRISPR-based assays, and nanotechnology-enhanced biosensors.

Usefulness & Problems

Why this is useful

CRISPR-based assays are named as a diagnostic platform category supported by the reporter systems discussed in the review. The abstract links them to viral imaging and detection use cases.; viral diagnostic platforms

Source:

CRISPR-based assays are named as a diagnostic platform category supported by the reporter systems discussed in the review. The abstract links them to viral imaging and detection use cases.

Source:

viral diagnostic platforms

Problem solved

They are presented as one route for viral detection and diagnostics.; supporting diagnostic readouts for viral detection

Source:

They are presented as one route for viral detection and diagnostics.

Source:

supporting diagnostic readouts for viral detection

Problem links

supporting diagnostic readouts for viral detection

Literature

They are presented as one route for viral detection and diagnostics.

Source:

They are presented as one route for viral detection and diagnostics.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Mechanisms

No mechanism tags yet.

Target processes

diagnosticediting

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

A CRISPR assay workflow is implied, but the abstract does not specify the nuclease system, reporter architecture, or instrumentation.; requires integration into a CRISPR-based assay workflow

The abstract does not clarify whether these assays are genetically encoded in the same way as the fluorescent proteins or how directly NIR FPs are coupled to the CRISPR readout.; the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application summarysupports2026Source 1needs review

These NIR FP reporters support real-time tracking of infection dynamics and host-virus interactions and are described as powering diagnostic platforms including reporter viruses, CRISPR-based assays, and nanotechnology-enhanced biosensors.

Claim 2engineering progress summarysupports2026Source 1needs review

The review states that iRFPs, monomeric miRFPs, and photoactivatable PAiRFPs have improved brightness, stability, and genetic encodability for robust use in mammalian models.

Claim 3future direction summarysupports2026Source 1needs review

The review presents structure-guided mutagenesis, computational or AI-assisted protein design, and hybrid imaging strategies as promising approaches to close current NIR FP performance and translation gaps.

Claim 4multimodal integration summarysupports2026Source 1needs review

The review states that integration of NIR FP systems with photoacoustic tomography and PET extends translational utility.

Approval Evidence

1 source1 linked approval claimfirst-pass slug crispr-based-assays
These reporters support real-time tracking of infection dynamics and host-virus interactions and power diagnostic platforms including reporter viruses, CRISPR-based assays, and nanotechnology-enhanced biosensors.

Source:

application summarysupports

These NIR FP reporters support real-time tracking of infection dynamics and host-virus interactions and are described as powering diagnostic platforms including reporter viruses, CRISPR-based assays, and nanotechnology-enhanced biosensors.

Source:

Comparisons

Source-stated alternatives

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Source-backed strengths

presented as part of diagnostic platform integration

Source:

presented as part of diagnostic platform integration

Compared with biosensors

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Shared frame: source-stated alternative in extracted literature

Strengths here: presented as part of diagnostic platform integration.

Relative tradeoffs: the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Shared frame: source-stated alternative in extracted literature

Strengths here: presented as part of diagnostic platform integration.

Relative tradeoffs: the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Shared frame: source-stated alternative in extracted literature

Strengths here: presented as part of diagnostic platform integration.

Relative tradeoffs: the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Shared frame: source-stated alternative in extracted literature

Strengths here: presented as part of diagnostic platform integration.

Relative tradeoffs: the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Shared frame: source-stated alternative in extracted literature

Strengths here: presented as part of diagnostic platform integration.

Relative tradeoffs: the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Compared with reporter viruses

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Shared frame: source-stated alternative in extracted literature

Strengths here: presented as part of diagnostic platform integration.

Relative tradeoffs: the abstract does not specify exact CRISPR assay formats or whether the NIR FP is the direct readout.

Source:

Reporter viruses and nanotechnology-enhanced biosensors are listed as alternative platform types.

Ranked Citations

  1. 1.

    Seeded from load plan for claim cl3. Extracted from this source document.